Dr. Reddy`s Laboratories jumps despite reporting 9% fall in Q2 consolidated net profit
Dr. Reddy's Laboratories is currently trading at Rs. 1300.55, up by 28.00 points or 2.20% from its previous closing of Rs. 1272.55 on the BSE.
The scrip opened at Rs. 1272.25 and has touched a high and low of Rs. 1322.00 and Rs. 1251.50 respectively. So far 110555 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1420.20 on 21-Aug-2024 and a 52 week low of Rs. 1,064.52 on 06-Nov-2023.
Last one week high and low of the scrip stood at Rs. 1322.00 and Rs. 1213.20 respectively. The current market cap of the company is Rs. 109892.64 crore.
The promoters holding in the company stood at 26.64%, while Institutions and Non-Institutions held 49.01% and 10.13% respectively.
Dr. Reddy's Laboratories has reported 57.81% rise in its net profit at Rs 1882.10 crore for second quarter ended September 30, 2024 (Q2FY25) as compared to Rs 1192.60 crore for the same quarter in the previous year. Total income of the company increased by 36.39% at Rs 6903.90 crore for Q2FY25 as compared to Rs 5061.80 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 9.47% fall in net profit at Rs 1341.90 crore for Q2FY25 as compared to Rs 1482.20 crore for the same quarter in the previous year. However, total income of the company increased by 15.63% at Rs 8345.70 crore for Q2FY25 as compared to Rs 7217.60 crore for the corresponding quarter previous year.
